Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FLUOXETINE
- Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.
- OptimizeD Pilot Study
- PEA vs. Placebo for Major Depression
- Department of Defense PTSD Adaptive Platform Trial Intervention A - Fluoxetine
- A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Depression
- Sequenced Treatment in Adolescents With Major Depression (STAMD): a Multicenter Open-label Randomized Controlled Trial
- Clinical Study of Cang Ai Volatile Oil (CAVO) on Mild to Moderate Depression in Children and Adolescents
- Effects of Paroxetine on Cardiovascular Function in Septic Patients
- Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)
- Bioequivalence Study of Fluoxetine in Healthy Adult Subjects Under Fasting Condition
- Vortioxetine Adjunctive Treatment in Bipolar Depression
- Fluoxetine Treatment of Depression in Down Syndrome
- Rapid Improvement of Depression of Fluoxetine Combined With ATP or Phosphocreatine
- Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine
- Digital Interventions as an Add-on Tool in Generalized Anxiety Disorder Treatment
- A Multicenter Clinical Study on Shuganjieyu Capsule Combined With Fluoxetine in the Treatment of Depression
- Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome
- Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea
- Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo
- Clinical Study on the Safety and Efficacy of Dental Pulp Mesenchymal Cells in the Treatment of Depression
- Treatment Interrupts Depression Early
- Study of Dextromethorphan in OCD and Related Disorders
- Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression
- Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma
- Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)
- The Canadian Maraviroc RCT To Augment Rehabilitation Outcomes After Stroke
- Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery Platform
- Fluoxetine vs CBT in Childhood Anxiety Disorders
- The Safety and Efficacy of Fluoxetine for Refractory Primary Mono-symptomatic Nocturnal Enuresis in Children
- Partners in Caring for Anxious Youth
- Sequenced Treatment Effectiveness for Posttraumatic Stress
- Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19)
- Fluoxetine to Reduce Intubation and Death After COVID19 Infection
- The Activation on Prefrontal Cortex With Acupuncture and Moxibustion for Major Depressive Disorder: A Study of Functional Near Infrared Spectroscopy
- Citalopram and Self Emotional Processing
- Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine Treatment
- Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
- The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients
- Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment
- Effect of Tamsulosin on PE Compared With Paroxetine Hydrochloride
- Poststroke Depression in Hemorrhagic Stroke
- Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment
- Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
- Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania
- Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
- Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial
- Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric (7-17 Years) With Major Depressive Disorder
- A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
- SMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research Project
- The Effect of G-DBT on the Patients With BN : A Multicenter Randomized Controlled Study
- Fluoxetine Opens Window to Improve Motor Recovery After Stroke
- OxSYPan: Oxford Study With Young People on Antidepressants
- Identifying and Treating Depression in Hemodialysis Patients
- The Effects of Fluoxetine and/or DHEA
- Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics
- Maraviroc to Augment Rehabilitation Outcomes After Stroke
- Randomized Clinical Trial of a Mindfulness Based Intervention in Generalized Anxiety Disorder
- Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity
- Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablets Under Fed Conditions
- Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions
- Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder
- Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI
- Measurement-based Care for Depression in Resource-Poor Settings
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- Serotonin Selective Reuptake Inhibitor (SSRI) Effects on Cerebral Connectivity in Acute Ischemic Stroke
- The Staged Treatment in Early Psychosis Study
- Fluoxetine for Visual Recovery After Ischemic Stroke
- Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
- Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)
- Efficacy of Fluoxetine - a Trial in Stroke
- A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
- Deep Brain Stimulation of NAc/ALIC to Prevent Treatment-Refractory Obsessive Compulsive Disorder
- Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
- Efficacy of Fluoxetine Against Seizure-induced Central Apneas
- Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?
- Study of Ibuprofen Effects on Brain Function
- Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome
- Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis
- Milk Thistle in Trichotillomania in Children and Adults
- Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging
- Acupuncture for Ischemic Post-stroke Depression
- Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment
- Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder
- Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome
- 16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression
- Pharmacovigilance in Gerontopsychiatric Patients
- Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)
- Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF.
- Fluoxetine vs Aripiprazole Comparative Trial (FACT)
- Milk Thistle in Pathological Gambling
- Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis
- Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury
- Intervention Study for Individuals With Compulsive Sexual Behavior
- The Gut Microbiota in Obsessive-Compulsive Disorder
- Bupropion for Depression in ESRD Patients on Hemodialysis
- Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients
- Comparison of Acupuncture and Fluoxetine on Quality of Life in Menopausal Women
- Evaluation of an Integrated Microfinance and Depression Care Program for Women
- "Evaluation by Transcranial Magnetic Stimulation of the Benefit of Fluoxetine on Motor Recovery After Stroke"
- A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity )
- Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients
- A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous Histamine Dihydrochloride for Migraine Prophylaxis
- An Adaptive Treatment Strategy for Adolescent Depression-Continuation
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- A Study of the Effect of Multiple Doses of Itraconazole and Fluoxetine on the Pharmacokinetics of a Single Dose of RO5285119 in Healthy Subjects
- RCT of a Neuroplasticity Agent and CI Therapy for Severe Arm Paresis After Stroke
- Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
- MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial
- Interpersonal Psychotherapy for Treatment Resistant Depression
- Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis
- Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment
- Duloxetine Treatment in Elderly With Dysthymia
- NMDA Antagonists in Bipolar Depression
- Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression
- A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
- A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
- An Adaptive Treatment Strategy for Adolescent Depression
- Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications
- Algorithm Guided Treatment Strategies for Major Depressive Disorder
- Comparison of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With Depression
- Fluoxetine for Motor Recovery After Acute Intracerebral Hemorrhage
- The Role of Antidepressants or Antipsychotics in Preventing Psychosis
- Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation
- Ketamine in the Treatment of Suicidal Depression
- Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
- Reducing Suicidal Ideation Through Insomnia Treatment
- A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
- Fluoxetine for Motor, Aphasia, and Neglect Recovery After Ischemic Stroke
- Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)
- Homeopathic Treatment for Depression in Peri- and Postmenopausal Women
- Fluoxetine Prevention Trial
- An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder
- Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression
- Minocycline for Bipolar Depression
- Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
- A Positron Emission Topographic (PET) Study on Depression Patient With Electroacupuncture
- Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
- The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity
- Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
- Neurophysiologic Monitoring of Antidepressant Treatment
- The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope
- Omega-3 and Therapy Study for Depression
- Anti-inflammatory Pulmonal Therapy of Cystic Fibrosis (CF) Patients With Amitriptyline and Placebo
- Cipralex® for Anxiety Disorders in Adolescents
- Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression
- Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial
- 90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions
- 90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions
- Lexapro for Major Depression in Patients With Epilepsy
- A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.
- Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
- Pharmacogenomics Studies of Antidepressants
- Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)
- Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial
- Efficacy and Safety of Homeopathy for Moderate Depression (Acute Phase)
- Electroacupuncture Combined With Antidepressants for Post-stroke Depression
- Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition
- Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed Condition
- Developing Adaptive Treatment Strategies for Children and Adolescents With Obsessive-compulsive Disorder.
- Fluoxetine in Multiple System Atrophy Patients
- Investigation of the Serotoninergic System in Multiple System Atrophy: a Positron Emission Tomography (PET) Study
- Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder
- Early Prediction of Fluoxetine Response
- Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease
- Treatment of Postpartum Depression With Psychotherapy and Add-on Sertraline
- Effect of Curcumin as Nutraceutical in Patients of Depression
- Topiramate Augmentation in Bulimia Nervosa Partial Responders
- Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy
- Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)
- Prevention of Relapse & Recurrence of Bipolar Depression
- A Study in Relapse Prevention of Treatment-Resistant Depression
- Light, Ion, and Fluoxetine Efficacy (LIFE) in Depression
- Trial of Aripiprazole in Trichotillomania
- To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg
- Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
- To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fasting Conditions
- To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fed and Fasted Conditions
- Brain Imaging Techniques That Predict Antidepressant Responsiveness
- Fluoxetine Essay in Children With Autism
- Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram
- A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
- A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
- Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder
- Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression
- Extended Management and Measurement of Autism
- Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression
- Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions
- Physiologic Monitoring of Antidepressant Treatment Response
- Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder
- Effectiveness of Stepped Care Versus Best Available Care for Bulimia Nervosa
- Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?
- Investigation of Drug-drug Interaction Between Clopidogrel and Fluoxetine
- Fluoxetine vs. Brief Psychotherapy for Major Depression
- A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder
- Group Cognitive Behavioral Therapy Versus Fluoxetine for Obsessive-Compulsive Disorder: a Practical Trial
- The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder
- Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women
- A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression
- Fluoxetine on Motor Rehabilitation After Ischemic Stroke
- Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation
- Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg
- Antidepressant Therapy for Bipolar II Major Depression
- Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure
- Brain Mechanisms and Targeting Insomnia in Major Depression
- Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder
- Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse
- Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning
- Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome
- Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features
- PET Imaging Study of Recovered Anorexics
- Antidepressant Therapy in Treating Bipolar Type II Major Depression
- Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder
- Hypoglycemia Associated Autonomic Failure in Type 1 DM
- An 8 Week Open-Label Study to Evaluate the Efficacy and Safety of Acamprosate Calcium (Campral) as Augmentation Therapy in Patients With Anxiety Symptoms Who Are Only Partial Responders to SSRI or SNRI Antidepressants
- Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
- Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease
- Hypericum vs Fluoxetine for Mild to Moderate Adolescent Depression
- Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder
- Duloxetine for Perimenopausal Depression
- Omacor for Perimenopausal Depression
- Study of Fluoxetine in Autism
- Subcutaneous Olanzapine for Hyperactive or Mixed Delirium
- Olanzapine in Patients With Advanced Cancer and Weight Loss
- Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression
- Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment
- Prevention of Mood Disorders by Folic Acid Supplementation
- A Placebo-Controlled Study of Mirtazapine for PTSD
- Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism
- Prozac Treatment of Major Depression: Discontinuation Study
- Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study
- Dichotic Listening as a Predictor of Medication Response in Depression
- Antidepressant Safety in Kids Study
- A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
- Treatment of Hypochondriasis With CBT and/or SSRI
- Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy
- Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents
- Nicotinic Receptor Augmentation of SSRI Antidepressants
- A Placebo-Controlled Study of Mirtazapine for PTSD
- Dichotic Listening as a Predictor of Medication Response in Depression
- Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa
- Lamotrigine in Treatment Resistant Depression in Adolescents
- Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation
- Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania
- Patient-Centered Collaborative Care for Preventing Post-Traumatic Stress Disorder After Traumatic Injury
- Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group
- Improving Sleep and Psychological Functioning in People With Depression and Insomnia
- Fluoxetine in Pediatric Body Dysmorphic Disorder
- A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder
- Maintenance Interpersonal Psychotherapy for Sustaining Remission of Depression
- Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?
- Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response
- A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
- Early Intervention With Fluoxetine in Autism
- Aripiprazole as Augmentation for TRD
- Cognitive Behavioral Therapy for Depression Relapse Prevention in Children and Adolescents
- A Study to Determine if Levetiracetam Will Assist Those Suffering From Chronic Idiopathic Axonal Polyneuropathy.
- Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence
- Phenytoin as an Augmentation for SSRI Failures
- Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts
- The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
- Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania
- Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia
- Escitalopram for the Treatment of Self-Injurious Skin Picking
- Fluoxetine as a Quit Smoking AID for Depression Prone
- Chronic Low Back Pain Research Project
- Determinants in Antidepressant Outcomes
- Treatment of Adolescent Suicide Attempters (TASA)
- A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder
- Substance Dependent Teens - Impact of Treating Depression Study 1 - 1
- Study Evaluating Venlafaxine ER in Recurrent Depression
- Relapse Prevention for Bipolar Type-II Disorder
- Treatment of Childhood Social Phobia
- The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression
- Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction
- Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression
- Study of Fluoxetine in Adults With Autistic Disorder
- Pharmacological Intervention Project (Fluoxetine)
- Riluzole to Treat Major Depression
- Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)
- Effect of Antidepressants on Back Pain
- Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers
- Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes
- Effect of Fluoxetine (Prozac) on Domestic Violence
- Treatment of Bulimia Nervosa in a Primary Care Setting
- Treatment for Adolescents With Depression Study (TADS)
- Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)
- Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
- Treatment of Depression in Youth With Bipolar Disorders
- Randomized Study of Fluoxetine in Children and Adolescents With Autism
- Study of Fluoxetine in Patients With Depersonalization Disorder
- Combining N-of-1 Trials to Assess Fibromyalgia Treatments
- Fluoxetine for Anxious Children
- Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)
- Treatment of Obsessive-Compulsive Disorder
- IV Cocaine Abuse: A Laboratory Model - 2
Clinical trials list
click for details